High-Risk Atrial Fibrillation in Patients with Cardiovascular Disease: Diagnosis, Comprehensive Risk Assessment, Comorbidities, and Anticoagulation Strategies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 8
Special Issue Editors
Interests: stroke; quality of life; psychology; nursing students; healthcare
Special Issues, Collections and Topics in MDPI journals
Interests: risk assessment; hypertensive; diabetes; atrial fibrillation; stroke; chronic diseases; cohort study
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to suggest a forthcoming Special Issue focusing on patients at high-risk for atrial fibrillation. Current clinical practice guidelines provide comprehensive frameworks for the management of diagnosed AF. However, a notable evidence gap persists concerning individuals exhibiting elevated thromboembolic risk who have not yet received an AF diagnosis. This often-overlooked cohort represents a vulnerable patient population with a significant propensity for future thromboembolic events, thus necessitating dedicated research to inform clinical practice.
This proposed Special Issue aims to address this critical knowledge deficit by soliciting original research and comprehensive reviews on various aspects pertinent to high-risk AF patients. We invite submissions focusing on, but not limited to, the following key areas:
- Thromboembolic Risk: Methodologies for the accurate assessment of thromboembolic risk in this specific patient population.
- Cardiovascular Comorbidity: Investigation into impact of associated cardiovascular comorbidities within the high-risk AF cohort.
- Associated Factors: Identification and characterization of genetic factors associated with an increased likelihood of AF development and adverse cardiovascular events.
- AF Burden Assessment: Advanced methodologies for quantifying AF burden, including the role and implications of device-detected atrial fibrillation (DDAF).
- Treatment Strategies: Evaluation of the efficacy and safety of diverse therapeutic approaches, encompassing initiatives such as CARE-AF and various anticoagulation strategies, tailored for this high-risk population.
We anticipate that contributions to this Special Issue will significantly advance the understanding and inform the clinical management of patients at high-risk for AF.
Dr. Silvia Reverté-Villarroya
Dr. José-Luis Clúa-Espuny
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- cardiovascular comorbidity
- device-detected atrial fibrillation
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
